AAPL 235.01 0.2602% MSFT 417.195 0.0012% NVDA 133.69 0.3453% GOOGL 190.66 -0.1832% GOOG 192.02 -0.1404% AMZN 220.31 0.8468% META 599.19 -1.5025% AVGO 226.12 0.3684% TSLA 415.11 2.9258% TSM 203.74 1.182% LLY 734.475 -7.9005% V 308.565 0.536% JPM 245.29 0.4422% UNH 537.99 -0.5821% NVO 81.145 -4.1066% WMT 91.485 -0.0492% LVMUY 134.55 0.6508% XOM 108.8074 -0.4416% LVMHF 675.0 1.6499% MA 504.77 -0.0277%
Last update at 2025-01-14T14:58:00Z
Is Sana Biotechnology (NASDAQ:SANA) In A Good Position To Deliver On Growth Plans?
Fri 18 Oct 24, 02:03 PMSana Biotechnology, Inc. (SANA): Jeff Bezos Is Buying This Stock Now
Sun 13 Oct 24, 08:48 PMInvaio Sciences Appoints André Andonian as Chairman of the Board of Directors
Thu 03 Oct 24, 12:00 PMSana Biotechnology Reports Second Quarter 2024 Financial Results and Business Updates
Thu 08 Aug 24, 08:05 PMMichelle Seitz Appointed to MSCI Inc. Board of Directors
Thu 01 Aug 24, 10:45 AM| Breakdown | 2022-12-31 | 2021-12-31 | 2020-12-31 | 2019-12-31 | 2018-12-31 |
|---|---|---|---|---|---|
| Type | yearly | yearly | yearly | yearly | yearly |
| Date | 2022-12-31 | 2021-12-31 | 2020-12-31 | 2019-12-31 | 2018-12-31 |
| Income before tax | -269.47600M | -355.92800M | -285.30500M | -138.32500M | - |
| Minority interest | - | - | - | - | - |
| Net income | -266.38800M | -344.18200M | -278.63700M | -130.77800M | - |
| Selling general administrative | 71.56M | 50.41M | 28.27M | 21.78M | - |
| Selling and marketing expenses | - | - | - | - | - |
| Gross profit | - | - | - | - | - |
| Reconciled depreciation | 15.62M | 11.07M | 5.92M | 1.83M | - |
| Ebit | -288.18900M | -367.97900M | -292.07000M | -141.15200M | -26.49200M |
| Ebitda | -272.56400M | -356.90900M | -286.14900M | -139.32600M | - |
| Depreciation and amortization | 15.62M | 11.07M | 5.92M | 1.83M | - |
| Non operating income net other | -0.67400M | 0.30M | - | - | - |
| Operating income | -272.56400M | -356.90900M | -286.14900M | -141.15200M | - |
| Other operating expenses | 272.56M | 356.91M | 286.15M | 141.15M | - |
| Interest expense | -15.62500M | 11.07M | 0.00000M | 2.83M | 0.00000M |
| Tax provision | - | 0.00000M | 0.00000M | -7.54700M | - |
| Interest income | 3.76M | 0.68M | 0.75M | 2.86M | - |
| Net interest income | 3.76M | 0.68M | 0.75M | 2.86M | - |
| Extraordinary items | - | - | - | - | - |
| Non recurring | - | - | - | - | - |
| Other items | - | - | - | - | - |
| Income tax expense | -3.08800M | -11.74600M | -6.66800M | -7.54700M | - |
| Total revenue | 0.00000M | 0.00000M | 0.00000M | 0.00000M | - |
| Total operating expenses | 272.56M | 356.91M | 286.15M | 141.15M | - |
| Cost of revenue | - | - | - | - | - |
| Total other income expense net | 3.09M | 0.98M | 0.84M | 2.83M | - |
| Discontinued operations | - | - | - | - | - |
| Net income from continuing ops | -269.47600M | -355.92800M | -285.30500M | -130.77800M | - |
| Net income applicable to common shares | -269.47600M | -355.92800M | -285.30500M | -130.77800M | -26.49400M |
| Preferred stock and other adjustments | - | - | - | - | - |
| Breakdown | 2023-12-31 | 2022-12-31 | 2021-12-31 | 2020-12-31 | 2019-12-31 |
|---|---|---|---|---|---|
| Type | yearly | yearly | yearly | yearly | yearly |
| Date | 2023-12-31 | 2022-12-31 | 2021-12-31 | 2020-12-31 | 2019-12-31 |
| Total assets | 565.30M | 822.72M | 1129.41M | 730.30M | 415.70M |
| Intangible assets | 59.20M | 59.20M | 59.20M | 59.20M | 59.20M |
| Earning assets | - | - | - | - | - |
| Other current assets | 4.49M | 14.37M | 7.11M | 6.20M | 5.28M |
| Total liab | 277.79M | 323.40M | 400.90M | 1151.48M | 558.24M |
| Total stockholder equity | 287.51M | 499.31M | 728.50M | -421.18400M | -142.54200M |
| Deferred long term liab |
US 
AU
UK
CA
NZ